Pharmaceutical Archivi - World Wide Trends

11 gennaio 2024

Fill-Finish Manufacturing Market is Led by the APAC Region

The fill-finish manufacturing market made a revenue of USD 10.1 billion in 2023, and it will touch a value of USD 20.7 billion by 2030, powering at a rate of 10.9% by the end of this decade, powered by the increasing requirement for injectables, as well as biologics and modified medicines.

This procedure plays a significant role in the pharma and biotech sectors by being the last stage in the production process, wherein biologic and synthetic drugs are dispensed into their containers and packed for distribution.

On the basis of the product, consumables led the industry with a share of 65%, in 2023, and it will be like this in the future as well. Consumables put to use in in the fill−finish procedure comprise vials, cartridges, syringes, caps, seals, stoppers, and filters.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=fill-finish-manufacturing-market-report

They are often single-use things, meaning they can be used once and then discarded. This trend of single-use consumables has become popular as a result of the growing requirement to decrease the risk of cross infection, attain faster changeovers amid diverse drug products, and minimalize capital investments and cost of maintenance.

Consequently, the requirement for consumables has augmented considerably, therefore powering the industry.

The fill-finish manufacturing market is powered by the growing requirement for injectable drugs. These drugs can be managed at once into the bloodstream or tissue with the help of injections. They are employed for the prevention, treatment, and management of numerous diseases, such as cancers, diabetes, autoimmune issues, and infections.

Such ailments need lasting treatment, often connecting the regular administration of injectable medications. As the existence of these diseases continues to increase, the requirement for parental drugs will also rise, thus contributing to the rise in the requirement for fill-finish services.

APAC was the leader of the pack, with a share of about 45%, in 2023, and this trend will continue in the years to come as well. The main region for this is that the region has a strong presence of pharma and biotech companies.

China, Japan, India, and South Korea are the hubs for pharma production and R&D activities. These have well-established pharma infra, a large and skilled workforce, and advantageous guidelines of the government supporting the development of related businesses.

Furthermore, more than a few biotech and pharma companies from Europe and North-America outsource their final-stage production process to firms based in the region on contract.

It is because of the growing demand for injectables and continuous advancements in technology all over the world, the demand for fill-finish manufacturing is on the rise, This trend will continue in the years to come as well.

23 agosto 2023

North America Leads Medical Gases and Equipment Industry

The medical gases and equipment industry will touch USD 33.84 billion by 2030, powering at a rate of 7.20%, as stated by a market research institution, P&S Intelligence, in one of its reports.

This is chiefly credited to the increasing incidence of chronic diseases globally. Furthermore, the spur in the size of the home healthcare industry, on top of tech- advancements, will boost the progress of the industry in the years to come.

Oxygen had the largest share, in the recent past, as a result of the occurrence of a large population of the patients suffering from respiratory ailments, including COPD, along with cardiac arrest, trauma, and severe bleeding. Furthermore, pure oxygen is put to use for the restoration of the tissue oxygen tension.

Also, the increasing patient count, which are in need of emergency care and ambulatory surgeries is thriving the advance of the category. Further, for the treatment of intoxication of a harmful substance and severe hypoxia, 100% oxygen must be directed through a face mask.

So, owing to the life-saving capability of O2, the category will continue to rule the segment in the years to come.

The therapeutic application dominated the market, with of over 40% share, in the past. This is as a result of the increasing usage of oxygen, medical air, nitric oxide, carbon dioxide, and helium as medication for the treatment of numerous conditions.

Moreover, medicinal oxygen is extensively employed in healthcare settings globally as complementary to anesthetic agents and in inhalation therapy. Furthermore, nitrous oxide is high in requirement in hospitals for use as an anesthetic, analgesic, and refrigerant in cryosurgical processes.

Hospitals had the largest share of over 27% in the industry. This is because of the increasing count of hospitals in both developed along with developing nations and their wide acceptance of carbon dioxide, liquid nitrogen, nitrogen protoxide, and medicinal air in ICUs, emergency rooms, and surgical rooms.

North America dominated the medical gases and equipment market with a share of over 35%, as a result of the increasing use of the related gases for the treatment along with CVD management, asthma, and COPD in hospitals, together with the high incidence of these ailments.

Moreover, the U.S. had the higher sales value, driven by the existence of a number of healthcare facilities. Also, because of the current growth in the usage of home-based therapy, the medical gas industry in the U.S. is facing a rise in standards, examination, and delivery processes.

Due to the increasing prevalence of pulmonary diseases all over the world, the demand for medical gases and equipment will continue to grow in the years to come.

31 luglio 2023

Europe Is Dominating Vials Industry

The global vials market is projected to be worth USD 3,047.0 million by 2030, growing at a CAGR of 8.6%, according to P&S Intelligence. This growth can be credited to the growing production volume of vial builders, growing healthcare investment, and the rising pharmaceutical sector. Furthermore, the rising demand for vials for the packing of COVID-19 vaccines is boosting industry growth.

In recent years, the borosilicate category had a larger share in the vials industry, on the basis of glass type. Moreover, the category is projected to remain in its dominant position in the future as well.

This is mainly because of the high fondness of vial manufacturing businesses for borosilicate glass because of its chemical inertness, thermal stability, and permeability. Such reasons have, therefore, caused the high requirement for borosilicate vials, mainly to help the continuing COVID vaccination programs throughout the world.

Pharmacological and biotech businesses are projected to establish the fastest-rising category in the vials industry in the coming few years, on the basis of the end user. This can be credited to the increasing demand for superior medications, such as biologics, armed with the rising elderly populace and age-associated ailments. Such reasons are boosting the demand for packing containers, like vials, among pharmacological and biotech businesses throughout the globe.

In recent years, Europe was the largest revenue generator of the vials market. This growth can be credited to the existence of crucial market companies, including Stevanato Group, Schott AG, Gerresheimer AG, and SGD S.A., development in end-use industries, rising elderly populace, augmented knowledge on newly advanced medications, and high disposable income in the continent.

Glass is the more favored material for vials for the vaccine fill–finish procedure, credited to its inertness, durability, robustness, which stops reaction with the medication, and robust resistance to delamination.

Compared to metals and plastics, glass is more appropriate for the main packing of high-end medicinal items. Furthermore, glass vials have a lengthier shelf lifespan and they are biodegradable and environment-friendly as well. Thus, the requirement for such vials is growing globally.

Customer growing knowledge regarding health-associated problems has augmented over the recent years. The growing epidemic of life-intimidating illnesses, like COVID-19, and the constant danger of contagions have resulted in awareness throughout the globe, which is further boosting the utilization of glass vials for medicinal packaging. The increasing expenditure on healthcare in emerging nations, like China and India, is also contributing to the development of the industry.

Hence, the growing production volume of vial builders, growing healthcare investment, and the rising pharmaceutical sector are the major factors contributing to the growth of the vials market.

6 giugno 2023

Medical Cartridges Industry Will Grow Fastest in the Asia-Pacific Region

The medical cartridges market will grow at a rate of 6.4% in the years to come to touch a value of USD 1,691.1 million by 2030. The factors accountable for the growth of the industry are growing pharma sector and increasing requirement for injectable pharma products.

Also, the surging elderly population and increasing occurrence of chronic and acute diseases will boost the requirement for medical cartridges all over the world.

On the basis of material type, the industry is categorized into plastic and glass. The glass category had larger share in the past, as stated by a market expert at P&S Intelligence.

Europe had the largest share in the medical cartridges market in the recent past. This is mostly credited to the increasing occurrence diabetes.

Also, deskbound lifestyle of people in the region is the main reason for obesity. For example, as per the IDF Diabetes Atlas Ninth Edition, about 59 million adults, who were aged 20–79 years suffered from diabetes in 2019.

Alternatively, APAC will grow the fastest in the years to come, because of the growing elderly population in the region, increasing incidence of diabetes, and expanding healthcare spending.

The growing pharma sector has an important role to play in the growth of the industry. The industry manufactures biologics and biosimilar drugs for managing a number of chronic diseases, for example diabetes, cancer, and rheumatoid arthritis. Some biopharma products are advanced and manufactured in the form of injectable therapeutic agents, administered through cartridges, vials, and prefilled syringes.

It is because of the aging elderly population around the world, and the developing pharma industry, the demand for medical cartridges will continue to grow in the years to come, globally.

16 maggio 2023

North America Is Dominating Microfluidic Devices Industry

The total value of the global microfluidic devices market was USD 14,218.6 million in 2021, and it will rise at a growth rate of above 17.3% shortly, reaching USD 59,785.3 million by 2030, according to P&S Intelligence.

Microfluidics is a developing scientific area with an extensive variety of logical applications and commercial diagnoses in the arenas of cell biology research, protein crystallization, and medicine. Therefore, this technology is a vital tool to decrease side effects and advance the effectiveness of treatments.

Furthermore, the requirement for micromachined biological tools is projected to grow considerably in the coming few years, driven by the development of genomics and proteomics studies, and also the aimed incorporation of lab-on-a-chip tools into laboratory measures.

In Asia-Pacific, China is one of the fastest-rising industries for microfluidics because of the growing government backing and refining of healthcare amenities. Consequently, APAC is projected to arise as an appealing industry for businesses manufacturing like medicinal instruments.

Whereas, in Europe, the industry is boosted by the growing diagnosis needs, credited to the refining healthcare amenities and the increasing occurrence of illnesses; itself because of the lifestyle changes and elderly populace.

In 2021, the polymer category led the industry with a share of approximately 60%. the polymer has experienced a substantial surge in the application, specifically in the rapid prototyping of microfluidic devices, credited to the material’s comfort of fabrication into items and reduced price. Moreover, new surface alterations are being launched to resolve the difficulties brought on by the hydrophobicity of polymers.

Hence, the industry for microfluidic devices is boosted by their increasing utilization in genomic and proteomic research.